We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont, Monsanto Ink Licensing Deal for Soybean Technology
Read MoreHide Full Article
DuPont (DD - Free Report) and Monsanto have signed a licensing agreement for one of Monsanto’s next-generation soybean technologies that will offer an additional option for farmers. Per the agreement, DuPont Pioneer will get a royalty-bearing license to Intacta RR2 PRO technology in Brazil.
The license will be granted following the customary review and prior approval by Brazilian regulatory authorities. Additional terms and financial details of the deal were not divulged.
DuPont Pioneer expects to bring the Intacta insect technology along with leading soybean genetics to Brazilian farmers in the 2017 selling season. The technology along with DuPont Dermacor seed treatment will enable the productivity of soybean growers while providing increased insect control and strengthening their integrated pest-management practices.
The agreement also reinforces the value of Intacta RR2 PRO platform, which is providing an important new choice in insect control and convenience to growers in South America. Intacta RR2 PRO soybeans provide three distinct benefits for growers – increased yield potential, protection against major pests that attack soybeans and tolerance to glyphosate herbicide.
DuPont reported adjusted earnings of $1.26 per share in first-quarter 2016, outperforming the Zacks Consensus Estimate of $1.02. Earnings were aided by cost saving plans. Sales of $7.4 billion for the reported quarter also beat the Zacks Consensus Estimate, despite currency headwinds and lower volumes. The company is undertaking an aggressive restructuring program this year, with numerous cost-cutting actions, including the layoff of 10% of its workforce.
DuPont currently holds a Zacks Rank #3 (Hold).
Better-ranked companies in the diversified chemicals industry include Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , both sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DuPont, Monsanto Ink Licensing Deal for Soybean Technology
DuPont (DD - Free Report) and Monsanto have signed a licensing agreement for one of Monsanto’s next-generation soybean technologies that will offer an additional option for farmers. Per the agreement, DuPont Pioneer will get a royalty-bearing license to Intacta RR2 PRO technology in Brazil.
The license will be granted following the customary review and prior approval by Brazilian regulatory authorities. Additional terms and financial details of the deal were not divulged.
DuPont Pioneer expects to bring the Intacta insect technology along with leading soybean genetics to Brazilian farmers in the 2017 selling season. The technology along with DuPont Dermacor seed treatment will enable the productivity of soybean growers while providing increased insect control and strengthening their integrated pest-management practices.
The agreement also reinforces the value of Intacta RR2 PRO platform, which is providing an important new choice in insect control and convenience to growers in South America. Intacta RR2 PRO soybeans provide three distinct benefits for growers – increased yield potential, protection against major pests that attack soybeans and tolerance to glyphosate herbicide.
DU PONT (EI) DE Price
DU PONT (EI) DE Price | DU PONT (EI) DE Quote
DuPont reported adjusted earnings of $1.26 per share in first-quarter 2016, outperforming the Zacks Consensus Estimate of $1.02. Earnings were aided by cost saving plans. Sales of $7.4 billion for the reported quarter also beat the Zacks Consensus Estimate, despite currency headwinds and lower volumes. The company is undertaking an aggressive restructuring program this year, with numerous cost-cutting actions, including the layoff of 10% of its workforce.
DuPont currently holds a Zacks Rank #3 (Hold).
Better-ranked companies in the diversified chemicals industry include Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , both sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>